bluebird bio Inc at JPMorgan Healthcare Conference Transcript
All right. Good afternoon, everyone. My name is Cory Kasimov, a senior biotech analyst at JPMorgan, and it's my pleasure to introduce our next company, bluebird bio. Here to present for the company is the Chief bluebird himself, Nick Leschly. And please note that following Nick's presentation, there's a breakout just across the hall in the Georgian Room.
So with that, I'll turn it over to Nick.
Thank you, Cory, and -- for that title introduction. I appreciate it. And thank you, everybody, for coming and JPMorgan for having me have the opportunity to represent bluebird and represent all the people that are here that are bluebirds also who are listening or who've been part of everything I'm about to describe. It really is an honor and a pleasure. And also thank you for all of you coming in. I know everyone has a lot of different choices and where they can go and how they can show up.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |